TNF Receptor Inhibitors

TNFRSF1A/CD120a

TNFRSF4

TNFRSF5/CD40

TNFRSF6/Fas/CD95

TNFRSF7/CD27

TNFRSF8/CD30

TNFRSF9/4-1BB/CD137

TNFRSF12A/TWEAK

TNFRSF16/NGF Receptor/CD271

TNFRSF18/GITR/CD357

TNF Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	TNFRSF1A/CD120a	TNFRSF4	TNFRSF5/CD40	TNFRSF6/Fas/CD95	TNFRSF7/CD27	TNFRSF8/CD30	TNFRSF9/4-1BB/CD137	TNFRSF12A/TWEAK	TNFRSF16/NGF Receptor/CD271	TNFRSF18/GITR/CD357	Purity
Etanercept				Fas							99.20%
R-7050			CD40								99.96%
Oxazolone	TNFR1										≥98.0%
Utomilumab							4-1BB				99.90%
TNF-α-IN-2			CD40, IC₅₀: 25 nM								98.75%
Brentuximab						CD30					99.64%
BIO8898			CD40L, IC₅₀: 25 μM								99.88%
Golimumab			CD40								99.71%
KR-33493				Fas							99.94%
Iscalimab			CD40, IC₅₀: 0.3 nM								99.64%
Mitazalimab			CD40								99.23%
Taurohyodeoxycholic acid sodium	TNFR1										99.60%
Toralizumab			CD40L								99.57%
Lucatumumab			CD40								98.18%
GSK2245035			CD40, pEC₅₀: 6.5								99.85%
Ragifilimab										GITR	≥99.0%
DRI-C25441			CD40, IC₅₀: 0.36 μM								99.53%
AQX-016A			CD40								98.00%
Enavatuzumab								TWEAK			≥99.0%
Letolizumab			CD40L
HDMAPP triammonium	TNFRSF1A
Cinrebafusp alfa							4-1BB, Kd: 5 nM				98.53%
Ravagalimab			CD40, EC₅₀: 3.7 nM								99.31%
Tecaginlimab			CD40				4-1BB				99.00%
DRI-C21041			CD40L, IC₅₀: 0.31 μM
TWEAK-Fn14-IN-1								TWEAK			98.59%
Maxadilan			TNF-α
AMG-228										GITR
EU-102										GITR
TQB2916			CD40
TRPM8 antagonist 4			TNF-α
Anti-inflammatory agent 17			TNF-α, IC₅₀: 2.576 μM
Relfovetmab									NGF
RG-7212 (RO5458640)								TWEAK			99.62%
Ranevetmab									NGF
MK-1248										GITR
TNF-α-IN-14			TNF-α, IC₅₀: 1.1 μM
FFP-104			CD40
Semapimod			CD40
MG-C-30					CD27, EC₅₀: 0.84 μM
(E)-C-HDMAPP ammonium	TNFRSF1A
HeFi-1						CD30
BIIB036								TNFRSF12A
Asperflavin			TNF-α
TNF-α-IN-15			TNF-α
TNF-α-IN-12			TNF-α
Cudraflavone B	TNFRSF1A
IBI356		OX40L
GSK1995057	TNFRSF1A
GSK2862277	TNFRSF1A

Name
Email *

	Sorry, but the email address you supplied was invalid.